BRPI0707629A2 - derivados de piperidina como antagonistas do receptor de cxcr3 - Google Patents
derivados de piperidina como antagonistas do receptor de cxcr3 Download PDFInfo
- Publication number
- BRPI0707629A2 BRPI0707629A2 BRPI0707629-0A BRPI0707629A BRPI0707629A2 BR PI0707629 A2 BRPI0707629 A2 BR PI0707629A2 BR PI0707629 A BRPI0707629 A BR PI0707629A BR PI0707629 A2 BRPI0707629 A2 BR PI0707629A2
- Authority
- BR
- Brazil
- Prior art keywords
- formula
- alkyl
- compound
- amino
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06101551.7 | 2006-02-10 | ||
| EP06101551 | 2006-02-10 | ||
| PCT/EP2007/051123 WO2007090836A2 (en) | 2006-02-10 | 2007-02-06 | Piperidine derivatives as cxcr3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0707629A2 true BRPI0707629A2 (pt) | 2011-05-10 |
Family
ID=35911097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0707629-0A BRPI0707629A2 (pt) | 2006-02-10 | 2007-02-06 | derivados de piperidina como antagonistas do receptor de cxcr3 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1983986A2 (ko) |
| JP (1) | JP2009526016A (ko) |
| KR (1) | KR20080093040A (ko) |
| CN (1) | CN101378756A (ko) |
| AR (1) | AR059427A1 (ko) |
| AU (1) | AU2007213744A1 (ko) |
| BR (1) | BRPI0707629A2 (ko) |
| CA (1) | CA2635138A1 (ko) |
| EA (1) | EA200870246A1 (ko) |
| IL (1) | IL193295A0 (ko) |
| NO (1) | NO20083856L (ko) |
| TW (1) | TW200811131A (ko) |
| WO (1) | WO2007090836A2 (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2771484A1 (en) | 2011-10-28 | 2014-09-03 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE632403A (ko) * | 1962-05-17 | 1900-01-01 | ||
| NZ530202A (en) * | 2001-07-02 | 2005-06-24 | Astrazeneca Ab | Piperidine derivatives useful as modulators of chemokine receptor activity |
-
2007
- 2007-02-06 AU AU2007213744A patent/AU2007213744A1/en not_active Abandoned
- 2007-02-06 EA EA200870246A patent/EA200870246A1/ru unknown
- 2007-02-06 KR KR1020087019298A patent/KR20080093040A/ko not_active Application Discontinuation
- 2007-02-06 CA CA002635138A patent/CA2635138A1/en not_active Abandoned
- 2007-02-06 BR BRPI0707629-0A patent/BRPI0707629A2/pt not_active Application Discontinuation
- 2007-02-06 WO PCT/EP2007/051123 patent/WO2007090836A2/en active Application Filing
- 2007-02-06 CN CNA2007800049228A patent/CN101378756A/zh active Pending
- 2007-02-06 EP EP07726319A patent/EP1983986A2/en not_active Withdrawn
- 2007-02-06 JP JP2008553749A patent/JP2009526016A/ja not_active Withdrawn
- 2007-02-09 AR ARP070100558A patent/AR059427A1/es unknown
- 2007-02-09 TW TW096104683A patent/TW200811131A/zh unknown
-
2008
- 2008-08-07 IL IL193295A patent/IL193295A0/en unknown
- 2008-09-08 NO NO20083856A patent/NO20083856L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2635138A1 (en) | 2007-08-16 |
| CN101378756A (zh) | 2009-03-04 |
| AR059427A1 (es) | 2008-04-09 |
| TW200811131A (en) | 2008-03-01 |
| WO2007090836A3 (en) | 2007-11-29 |
| JP2009526016A (ja) | 2009-07-16 |
| AU2007213744A1 (en) | 2007-08-16 |
| IL193295A0 (en) | 2009-08-03 |
| KR20080093040A (ko) | 2008-10-17 |
| EP1983986A2 (en) | 2008-10-29 |
| NO20083856L (no) | 2008-11-04 |
| EA200870246A1 (ru) | 2009-02-27 |
| WO2007090836A2 (en) | 2007-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10464934B2 (en) | Substituted tetrahydropyrans as CCR2 modulators | |
| AU2001283345B2 (en) | Cyclopentyl modulators of chemokine receptor activity | |
| KR102031846B1 (ko) | Ｃｃｒ(4) 길항제로서의 치환된 벤즈이미다졸 및 벤조피라졸 | |
| JP4440257B2 (ja) | ケモカイン受容体のベンゾオキサジニル−アミドシクロペンチル−複素環式モジュレーター | |
| MX2008009512A (es) | Derivados de piperidinilo como moduladores de la actividad del receptor de quimiocina. | |
| KR102000770B1 (ko) | Ｃｃｒ(4) 길항제로서의 치환된 아닐린 | |
| WO2004094371A2 (en) | Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity | |
| ES2432570T3 (es) | Derivados cíclicos como moduladores de la actividad de los receptores de quimiocinas | |
| JP3911006B2 (ja) | 化学化合物 | |
| JP4748162B2 (ja) | Ｎ−ジヒドロキシアルキル置換２−オキソイミダゾール誘導体 | |
| CN1964964A (zh) | 用于治疗趋化因子介导的疾病的哌啶衍生物 | |
| ES2424661T3 (es) | Hidroxialcanil amidas como moduladores de la actividad del receptor de quimioquina | |
| BRPI0707629A2 (pt) | derivados de piperidina como antagonistas do receptor de cxcr3 | |
| JP2007500758A (ja) | ケモカイン受容体活性のモジュレーターとしてのｎ−ウレイドアルキル−ピペリジン | |
| CA2635137A1 (en) | Piperidine derivatives as cxcr3 receptor antagonists | |
| MX2008010293A (es) | Derivados de piperidina como antagonistas del receptor de cxcr3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |